Keyphrases
Meta-analysis
100%
Interferon-α (IFN-α)
100%
Randomized Trial
100%
High-risk Melanoma
100%
Adjuvant Interferon
100%
Overall Survival
50%
Recurrence-free Survival
50%
Confidence Interval
33%
High Risk
16%
Adjuvant Therapy
16%
Hazard Ratio
16%
Increased Dose
16%
Survival Benefit
16%
Survival Trends
16%
Published Data
16%
Dose-response Relationship
16%
Subgroup Analysis
16%
Individual Patient Data Meta-analysis
16%
Survival Study
16%
Malignant Melanoma
16%
Significant Trend
16%
Quantitative Meta-analysis
16%
Testing Trends
16%
Nursing and Health Professions
Meta Analysis
100%
Melanoma
100%
Interferon
100%
Overall Survival
37%
Recurrence Free Survival
37%
Confidence Interval
25%
Recurrent Disease
12%
Hazard Ratio
12%
Adjuvant Therapy
12%
Patient Coding
12%
Medicine and Dentistry
Meta-Analysis
100%
Interferon
100%
Melanoma
100%
Overall Survival
37%
Recurrence Free Survival
37%
Recurrent Disease
12%
Hazard Ratio
12%
Adjuvant Therapy
12%
Dose Response
12%
Patient-Data
12%
Subgroup Analysis
12%
Pharmacology, Toxicology and Pharmaceutical Science
Melanoma
100%
Interferon
100%
Overall Survival
37%
Recurrence Free Survival
37%
Recurrent Disease
12%
Dose-Response Relationship
12%
Neuroscience
Meta-Analysis
100%
Interferon
100%
Adjuvant Therapy
12%